Abstract: Gorlin's syndrome is an autosomal dominant disorder, mainly characterized by the presence of multiple and early-onset basal cell carcinomas, odontogenic keratocysts and palmoplantar pits. We describe the case of a patient with clinical and imaging features of Gorlin syndrome, and highlight the role of dermoscopy in the early detection of basal cell carcinomas. In addition, we discuss the dermoscopic features of palmar pits.
INTRODUCTION
Gorlin's syndrome (GS) or nevoid basal cell carcinoma syndrome is an autosomal dominant disorder caused by mutations in PTC, the human homologue of the Drosophila patched gene. This condition has a variable phenotypic expression, probably due to the interaction of genetic and environmental factors. Common features include the presence of multiple and early-onset basal cell carcinomas (BCC), odontogenic keratocysts (OKC) of the jaw, palmoplantar pits, broad forehead, rib anomalies, calcifi ed falx cerebri, and other developmental anomalies and neoplasms.
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CASE REPORT
A 50-year-old female with a history of uterine fi broma (UF) and right cheek BCC excised 26 and 7 years before, respectively, presented for the evaluation of 3 nodular lesions on the face, which were clinically suggestive of BCC. Additionally, she reported frequent back pain and exhibited multiple milia scattered over her face, coarse facies with hypertelorism and prognathism, and mild palmar pitting (Figure 1 ). Attentive skin examination and dermoscopy disclosed a total of 8 lesions suggestive of BCCs. The most commonly observed dermoscopy features were: arborizing vessels, ulceration, blue-gray globules and spokewheel areas (Figure 2 ). Dermoscopy also enabled a better visualization of the palmar pits, and revealed fl esh-colored, irregular-shaped and slightly depressed lesions, some of them with red globules inside ( Figure  3 ). The patient's mother had died at the age of 65 years due to destructive BCC of the periorbital area. Her 26-year-old daughter had a history of OKC of the jaw and UF excised at the ages of 17 and 19 years, respectively; 3 facial BCCs, the fi rst having been removed at 19 years of age; hypertelorism; prognathism; milia on the face and severe palmar pits ( Figure 4) . Two of the proband's brothers had also underwent excision of multiple BCCs since their 4 th decade of life. Imag- ing studies (skull, face, chest and spine X-ray and CT scan) disclosed calcifi cation of the cerebral falx, OKC of the left jaw, bilateral bifi d ribs, marked dextroconvex dorsal scoliosis associated with hemivertebra, and prominent transverse processes of C7 ( Figure 5 ). ECG, abdomino-pelvic US and ophthalmological examination were normal. Based on the clinical and radiological features, and the family history, our patient was diagnosed as having a familial GS. The facial tumors were excised, and the diagnosis of BCC was confi rmed histologically in all lesions included in this study.
DISCUSSION
The clinical diagnosis of GS is based on the presence of multiple BCCs and palmoplantar pits, in association with internal abnormalities and skeletal defects. With dermoscopy, BCCs in GS can be detected in early stages by the presence of typical, but often subtle, dermoscopic features of BCC. Acral pits, which are often overlooked during physical examination, have a characteristic dermoscopy and can be easily visualized with this tool. 2, 3 Additionally, the role of dermoscopy in predicting tumor subtype has been demonstrated, and this may infl uence the choice of treatment. Maple leaf-like areas, short fi ne superficial telangiectasia, multiple small erosions, and shiny white-red structureless areas seem to be potent predictors of superfi cial BCC, while the presence of arborizing vessels, blue-gray ovoid nests, and ulceration increases the possibility of the diagnosis of non-superfi cial BCCs. 4 Although sporadic human BCC are generally well managed with excisional surgery, considering the number and characteristic recurrent nature of the lesions in GS, several alternative approaches have been used -alone or in combination -, including ablative laser therapy, electrocoagulation, cryosurgery, photodynamic therapy, topical imiquimod and 5-fl uorouracil. 5 Unfortunately, there are no large-scale studies on the treatment of BCCs in this syndrome. The choice of treatment is generally based on a combination of factors, which include: available clinical evidence, patient and tumor characteristics, patient's choice, local availability of specialized services, and experience and preferences of the physician. The development of an oral hedgehog pathway inhibitor, vismodegib, has raised a new dimension to the current treatment of BCCs. The recent demonstration that vismodegib additionally shrinks some OKCs in patients with GS will surely increase the interest in the drug when treating patients with this syndrome. 6 This case was unusual in that the patient presented with most of the clinical and imaging criteria for diagnosing GS, as defi ned by Kimonis et al.. 1 The decision to surgically excise the BCCs was based on several factors, such as clinical and dermoscopy fea- tures predicting non-superfi cial subtype in most of the lesions, the patient's will, the availability of technics, and the experience and preference of the specialist physician involved. We intend to emphasize that a regular dermatological examination is recommended for all patients with GS, so that BCCs can be early diagnosed and treated. A continuous and multidisciplinary approach, as well as a follow-up are essential, given the diverse clinical manifestations patients can present throughout life. These recommendations might help avoid possible complications and thus improve quality of life.❑
